Furthermore, varying degrees of IL-33 upregulation have been identified in patients with cystic fibrosis and silicosis, indicating a potential role for IL-33 in the pathogenesis of these diseases, necessitating further investigation in the future (99, 100). The gene discussed is IL33; the disease is cystic fibrosis.